| Date | Title | Description |
| 06.10.2025 | Owlstone Medical wins up to $49.1M ARPA-H award to pioneer breath-based cancer detection | UK medtech Owlstone Medical has won an award of up to $49.1 million from the Advanced Research Projects Agency for Health (ARPA-H) for the Platform Optimising SynBio for Early Intervention and Detection in Oncology (POSEIDON https://arpa-h.... |
| 25.03.2025 | Owlstone Medical announces investment of up to $2.3 Million USD from the Cystic Fibrosis Foundation to develop a breath test for Pseudomonas aeruginosa detection in Cystic Fibrosis patients | Test to be developed for Pseudomonas aeruginosa detection in patients with cystic fibrosis suitable for both detection of new cases and monitoring of chronic infection
Support to demonstrate proof of principle in chronic infection to be pro... |
| 26.01.2025 | Owlstone Medical: $27 Million First Close Of Series E Closed | Owlstone Medical, a leader in Breath Biopsy for early disease detection and precision medicine applications, announced the first closing of $27 million (circa £22 million) in its Series E funding round. The fundraiser was led by Ventura Cap... |
| 16.01.2025 | Owlstone Medical's $27 Million Leap: A Breath of Fresh Air in Diagnostics | Owlstone Medical is on the rise. The Cambridge-based company has just secured $27 million in its Series E financing round. This funding is a game-changer. It promises to accelerate the development of innovative diagnostic tests that could r... |
| 15.01.2025 | Owlstone Medical announces $27 Million USD first close in Series E financing round | Led by Ventura Capital and joined by other investors including Aviva Ventures, the Gates Foundation and Horizons Ventures
Funding will be used to accelerate commercialization and further clinical trials of Breath Biopsy diagnostic tests and... |
| 15.01.2025 | Owlstone Medical Raises USD$27M in First Close of Series E Financing | Owlstone Medical, a Cambridge, UK-based company which specializes in Breath Biopsy® for applications in early disease detection and precision medicine, announced a first closing of $27M in its Series E funding.
The round was led by Ventura ... |
| 26.04.2024 | Owlstone Medical Secures Funding for Breath-Based Diagnostics | Owlstone Medical, a UK-based company specializing in Breath Biopsy® for early disease detection, secured $6.5 million in funding. The funding includes a $5 million equity investment and a $1.5 million grant from the Bill & Melinda Gates... |
| 25.04.2024 | Owlstone Medical Raises $6.5M in Funding | Owlstone Medical, a Cambridge, UK-based company which specialises in Breath Biopsy® for applications in early disease detection and precision medicine, raised $6.5M in funding.
The round was comprised of a $5M equity investment to advance O... |
| 25.04.2024 | Owlstone Medical secures $6.5 million to support development of breath-based diagnostics for infectious disease | $5 million equity investment and initial $1.5 million grant funding committed by the Bill & Melinda Gates Foundation for development of breath-based diagnostic solutions to improve outcomes in the developing world
Funding represents the... |
| 04.04.2023 | Owlstone Medical Launches OMED Health to Enable Patients to Better Understand their Gut Microbiome and Manage their Digestive Health | Breath-based analysis technology and digital platform offers a science-backed approach to helping individuals monitor and treat their gut health and understand their microbiome
Supported by gastrointestinal experts, information can be used ... |
| 07.12.2022 | Owlstone Medical launches Breath Biopsy VOC Atlas | Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the launch of the Breath Biopsy VOC Atlas, a catalogue of validated and quantitated volat... |
| 08.09.2021 | Coinbase takes its SEC battle to the public | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
Paid Content How this advanced tech will help machines see like humans From Telus International
F... |
| 08.09.2021 | Coinbase takes its SEC battle to the public | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
Paid Content Why the marketer experience needs a digital upgrade From Optimizely
Few CEOs take th... |
| 07.09.2021 | Owlstone Medical closes £42m oversubscribed financing round to continue to advance breath biopsy | Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the close of its Series D financing round. Due to the high level of interest in this capital raise, th... |
| 07.09.2021 | Owlstone Medical Raises $58M in Funding | Owlstone Medical, a Cambridge UK-based global leader in Breath Biopsy® for applications in early disease detection and precision medicine, raised $58M in funding.
The round was led by Horizons Ventures, which now takes a seat on Owlstone Me... |
| 07.09.2021 | Breath biopsy company Owlstone Medical hoovers up $58M funding round
How to Optimize In Vitro and In Vivo Data Analysis and Data Management in Drug Research | To help further its work to catalogue the countless compounds we exhale—and provide a closer look into our health—Owlstone Medical raised $58 million to support its efforts in the field of breath biopsy.
RELATED: Owlstone's breath-based bio... |
| 07.09.2021 | Owlstone Medical closes £42m oversubscribed financing round to continue to advance breath biopsy | Owlstone Medical closes £42m oversubscribed financing round to continue to advance breath biopsy
07-09-2021
Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today anno... |
| 07.09.2021 | Breath biopsy company Owlstone Medical hoovers up $58M funding round | To help further its work to catalogue the countless compounds we exhale—and provide a closer look into our health—Owlstone Medical raised $58 million to support its efforts in the field of breath biopsy.
The former Fierce 15 winner’s system... |
| 28.05.2021 | Owlstone Medical's annual Breath Biopsy Conference is online this autumn | Owlstone Medical's annual Breath Biopsy Conference is online this autumn
28-05-2021
Owlstone Medical's next Breath Biopsy Conference (BBCon21) will be held on the 12th & 13th October. The firm is keen to keep reaching global audiences, ... |
| 18.05.2021 | Owlstone Medical launches breath testing for digestive health | Owlstone Medical (OML), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced agreements with Functional Gut Clinic (FGC) and Functional Gut Diagnostics (FGD), leading provid... |
| 18.05.2021 | Owlstone Medical launches breath testing for digestive health | Owlstone Medical launches breath testing for digestive health
18-05-2021
Owlstone Medical (OML), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced agreements with Functio... |
| 11.12.2020 | Owlstone Medical expands US operations and establishes permanent US office | Owlstone Medical expands US operations and establishes permanent US office
11-12-2020
Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announces that it has take... |
| 11.12.2020 | Owlstone Medical expands US operations and establishes permanent US office | Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announces that it has taken important steps to better support its pharmaceutical and academic customers in the U... |
| 22.09.2020 | Owlstone Medical announces key study results on use of breath biopsy for improved detection of liver disease | Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the results of a patient study that successfully demonstrates the use of exhaled limonene as a breath ... |
| 22.09.2020 | Owlstone Medical announces key study results on use of breath biopsy for improved detection of liver disease | Owlstone Medical announces key study results on use of breath biopsy for improved detection of liver disease
22-09-2020
Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine... |
| 12.03.2020 | Cofinitive shortlisted in 30th Anniversary Business Weekly Awards | Cofinitive shortlisted in 30th Anniversary Business Weekly Awards
12-03-2020
Cofinitive are delighted to announce that they have been shortlisted in the upcoming Business Weekly Awards.
The shortlist has listed us as “a growing team of comm... |
| 29.10.2019 | Owlstone Medical to contribute breath biopsy to 3TR, the largest-ever IMI2 immunology project | Owlstone Medical to contribute breath biopsy to 3TR, the largest-ever IMI2 immunology project
29-10-2019
Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine has joined 3TR... |
| 27.06.2019 | Singapore to invest $30 million in 5G tests ahead of 2020 rollout | By Reuters Staff
2 Min Read
FILE PHOTO - A logo of the upcoming mobile standard 5G is pictured at the Hanover trade fair, in Hanover, Germany March 31, 2019. REUTERS/Fabian Bimmer
SINGAPORE (Reuters) - Singapore on Thursday launched a S$40 ... |
| 18.06.2019 | Owlstone Medical announces a novel approach to breath-based testing for investigation of the onset, progression, and treatment of disease | Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announces the development of an innovative alternative approach to breath-based testing through the utilization ... |
| 18.06.2019 | Owlstone Medical announces a novel approach to breath-based testing for investigation of the onset, progression, and treatment of disease | Owlstone Medical announces a novel approach to breath-based testing for investigation of the onset, progression, and treatment of disease
18-06-2019
Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease det... |
| 20.05.2019 | Owlstone Medical enters into a strategic collaboration with Actelion | Owlstone Medical enters into a strategic collaboration with Actelion
20-05-2019
Owlstone Medical and Actelion collaborate to develop a breath-based test to help facilitate early detection of pulmonary hypertension.
Owlstone Medical, the glo... |
| 27.02.2019 | Cofinitive shortlisted for International Trade Champion award at Business Weekly Awards | Cofinitive shortlisted for International Trade Champion award at Business Weekly Awards
27-02-2019
Cofinitive is delighted to announce it has been shortlisted among the brightest and best of elite Cambridge-based companies in the upcoming B... |
| 20.02.2019 | Owlstone Medical and Shanghai Hospital to pioneer breath biopsy lung cancer trial in China | Owlstone Medical and Shanghai Hospital to pioneer breath biopsy lung cancer trial in China
20-02-2019
Owlstone Medical Ltd., a global diagnostics company developing a breathalyzer for applications in early disease detection and precision me... |
| 03.01.2019 | Clinical trial launches to develop breath test for multiple cancers | Owlstone Medical, a global diagnostics company developing a breathalyzer for applications in early disease detection and precision medicine, and Cancer Research UK, today announce the clinical launch of the PAN Cancer trial for Early Detect... |
| 03.01.2019 | Clinical trial launches to develop breath test for multiple cancers | Clinical trial launches to develop breath test for multiple cancers
03-01-2019
Owlstone Medical, a global diagnostics company developing a breathalyzer for applications in early disease detection and precision medicine, and Cancer Research ... |
| 02.10.2018 | Owlstone Medical completes $50m (c.£38m) financing round | Owlstone Medical completes $50m (c.£38m) financing round
02-10-2018
Owlstone Medical Ltd, a global diagnostics company developing a breathalyzer for applications in early disease detection and precision medicine, announced that it has compl... |
| 02.10.2018 | Owlstone Medical from Cambridge raises $35 million for its breathalyser-based diagnostics solution | Cambridge-based scale-up Owlstone Medical has raised $35 million as part of a larger $50 million funding round, the first $15 million of which was closed in March this year. The current funding deal was led by Horizons Ventures, joined by a... |
| 19.07.2018 | Owlstone Medical appoints five leading experts to Scientific Advisory Board | Owlstone Medical appoints five leading experts to Scientific Advisory Board
19-07-2018
Owlstone Medical (or the “Company”), a diagnostics company developing a breathalyzer for disease, has announced the expansion of its Scientific Advisory ... |
| 20.04.2018 | Owlstone Medical expands headquarters at Cambridge Science Park | Innovative diagnostics company Owlstone Medical - pioneers of a breathalyser with the potential to revolutionise the early detection of cancer - has committed its future to Cambridge Science Park by expanding its headquarters on site.
The v... |
| 20.04.2018 | Owlstone Medical expands headquarters at Cambridge Science Park | Owlstone Medical expands headquarters at Cambridge Science Park
20-04-2018
Innovative diagnostics company Owlstone Medical - pioneers of a breathalyser with the potential to revolutionise the early detection of cancer - has committed its fu... |
| 10.04.2018 | Owlstone Medical collaboration with AstraZeneca illustrates applications of breath biopsy kit | In an interview last year, Owlstone Medical Billy Boyle co-founder and CEO said that what makes the company’s technology unique is that users can program what they’re trying to detect just by changing the software. Breath contains about a t... |
| 28.03.2018 | Owlstone Medical launches Breath Biopsy Kits | Owlstone Medical launches Breath Biopsy Kits
28-03-2018
Owlstone Medical, a diagnostics company developing a breathalyzer for disease, today announced the launch of its Breath Biopsy® Kits, based on the company’s proprietary Breath Biopsy p... |
| 28.03.2018 | Owlstone Medical launches Breath Biopsy Kits | Owlstone Medical, a diagnostics company developing a breathalyzer for disease, today announced the launch of its Breath Biopsy® Kits, based on the company’s proprietary Breath Biopsy platform. The new product range allows academic, clinical... |
| 27.03.2018 | Onespacemedia launches new brand and website for Cambridge Science Park | Onespacemedia launches new brand and website for Cambridge Science Park
27-03-2018
The Onespacemedia team has launched a new branding and web design project for the Cambridge Science Park, Europe’s oldest and most successful science park.
T... |
| 27.03.2018 | Onespacemedia launches new brand and website for Cambridge Science Park | The Onespacemedia team has launched a new branding and web design project for the Cambridge Science Park, Europe’s oldest and most successful science park.
This is the latest project in Onespacemedia’s expanding portfolio of clients in the ... |
| 06.03.2018 | Owlstone Medical raises £11 million with Horizons Ventures and Aviva | Owlstone Medical Ltd, a diagnostics company developing a breathalyzer for disease, announced today that it has raised $15 million (£11 million) to drive the global commercialization of its Breath Biopsy® platform. The funds will enable the ... |
| 06.03.2018 | Owlstone Medical raises £11 million with Horizons Ventures and Aviva | Owlstone Medical raises £11 million with Horizons Ventures and Aviva
06-03-2018
Owlstone Medical Ltd, a diagnostics company developing a breathalyzer for disease, announced today that it has raised $15 million (£11 million) to drive the glo... |
| 05.03.2018 | Owlstone Medical Raises $15M in Funding | Owlstone Medical Ltd, a Cambridge, England, UK-based diagnostics company developing a breathalyzer for disease, raised $15m (£11 million) in funding.
The round was co-led by Horizons Ventures, the private investment arm of Mr. Li Ka-shing, ... |
| 27.11.2017 | Onespacemedia launches second website for chemical detection pioneer Owlstone | Onespacemedia launches second website for chemical detection pioneer Owlstone
27-11-2017
The Onespacemedia team has launched a second website for the Owlstone family of companies, following the recent launch of a site for clinical diagnosti... |
| 27.11.2017 | Onespacemedia launches second website for chemical detection pioneer Owlstone | The Onespacemedia team has launched a second website for the Owlstone family of companies, following the recent launch of a site for clinical diagnostics arm, Owlstone Medical - adding to a growing number of international clients.
Owlstone ... |
| 23.05.2017 | Owlstone Medical appoints Professor Sir Bruce Ponder to new Scientific Advisory Board | Owlstone Medical appoints Professor Sir Bruce Ponder to new Scientific Advisory Board
23-05-2017
Owlstone Medical, a diagnostics company developing a breathalyzer for disease, announced today the appointment of Professor Sir Bruce Ponder FR... |
| 27.03.2017 | Owlstone Medical Receives Investment from Aviva Ventures | Owlstone Medical Ltd, a Cambridge, England, UK-based diagnostics company developing a breathalyzer for disease, received an investment from Aviva Ventures, the venture capital arm of global insurance company Aviva plc.
The investment takes ... |
| 06.01.2017 | Owlstone Medical Raises Approx. £9.3M in Funding | Owlstone Medical Ltd, a Cambridge, England, UK-based diagnostics company developing a breathalyzer for disease, raised $11.55m (approx. £9.3m) in funding.
The round, which follows the original investment of $7m (£4.9m) in June 2016, was led... |
| 06.01.2017 | Owlstone Medical announces £9.3M fundraising | Owlstone Medical Ltd, a diagnostics company developing a breathalyzer for disease, today announced that it has successfully raised £9.3 million ($11.55 million USD) financing. The investment round was led by existing investors, and will be ... |
| 06.01.2017 | Owlstone Medical announces £9.3M fundraising | Owlstone Medical announces £9.3M fundraising
06-01-2017
Owlstone Medical Ltd, a diagnostics company developing a breathalyzer for disease, today announced that it has successfully raised £9.3 million ($11.55 million USD) financing. The inve... |
| 28.06.2016 | Owlstone Medical closes $7M (£4.9M) investment to commercialise disease breathalyzer | Owlstone Medical Ltd, a diagnostics company, has been spun out of parent company, Owlstone Inc, to develop and commercialise a breathalyzer for use in clinical diagnostics and precision medicine with applications in cancer, inflammatory and... |
| 28.06.2016 | Diagnostics Company Owlstone Medical Raises $7M in Funding | Owlstone Medical, Ltd, a Cambridge, UK-based diagnostics company, raised $7m (£4.9m) in funding.
The round was led by Medtekwiz Advisory Ltd.
The company intends to use the funds for ongoing clinical trials of the breathalyzer in lung and c... |
| 28.06.2016 | Owlstone Medical closes $7M (£4.9M) investment to commercialise disease breathalyzer | Owlstone Medical closes $7M (£4.9M) investment to commercialise disease breathalyzer
28-06-2016
Owlstone Medical Ltd, a diagnostics company, has been spun out of parent company, Owlstone Inc, to develop and commercialise a breathalyzer for ... |
| - | Owlstone Medical: Breath Biopsy Company Raises $6.5 Million | Owlstone Medical, a global leader in Breath Biopsy for early disease detection and precision medicine applications, has secured funding from the Bill & Melinda Gates Foundation. This funding round comprises a $5 million equity investmen... |
| - | Owlstone Medical | - |
| - | Owlstone Medical collaboration with AstraZeneca illustrates applications of breath biopsy kit | reCIVA breath sampler from Owlstone Medical
Owlstone Medical, the Cambridge, UK-based diagnostics spinoff of Owlstone, has formed a partnership with pharma company AstraZeneca. The partnership is designed to support the use of Owlstone Medi... |
| - | Owlstone Medical | “A breathalyzer for disease. Breath Biopsy: The leader in non-invasive breath biomarker research and breath test development.” |
| - | Owlstone Medical | “A breathalyzer for disease. Breath Biopsy: The leader in non-invasive breath analysis for VOC biomarker research and breath test development.” |
